Literature DB >> 20397080

Acceptability and adherence of a candidate microbicide gel among high-risk women in Africa and India.

Elizabeth Greene1, Georges Batona, Jyoti Hallad, Sethulakshmi Johnson, Stella Neema, Elizabeth E Tolley.   

Abstract

Vaginal microbicides currently under development are substances that may prevent the transmission of HIV. Qualitative, in-depth post-trial interview data from a Phase III clinical trial of 6% Cellulose Sulfate microbicide gel in two sites in Africa (Uganda and Benin) and two in India (Chennai and Bagalkot) were examined in order to better understand factors that influence microbicide acceptability and adherence in a clinical trial setting. Women found the gel relatively easy to use with partners with whom there were no expectations of fidelity, in situations where they had access to private space and at times when they were expecting to engage in sexual intercourse. Adherence to gel seemed significantly more difficult with primary partners due to decreased perceptions of risk, inconvenience or fear of partner disapproval. Findings suggest that women in a variety of settings may find a microbicide gel to be highly acceptable for its lubricant qualities and protective benefits but that adherence and consistent use may depend greatly on contextual and partner-related factors. These findings have important implications for future trial designs, predicting determinants of microbicide use and acceptability and marketing and educational efforts should a safe and efficacious microbicide be found.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20397080     DOI: 10.1080/13691051003728599

Source DB:  PubMed          Journal:  Cult Health Sex        ISSN: 1369-1058


  40 in total

Review 1.  Microbicides: topical prevention against HIV.

Authors:  Robin J Shattock; Zeda Rosenberg
Journal:  Cold Spring Harb Perspect Med       Date:  2012-02       Impact factor: 6.915

2.  Designing preclinical perceptibility measures to evaluate topical vaginal gel formulations: relating user sensory perceptions and experiences to formulation properties.

Authors:  Kathleen M Morrow; Joseph L Fava; Rochelle K Rosen; Sara Vargas; Julia G Shaw; E Milu Kojic; Patrick F Kiser; David R Friend; David F Katz
Journal:  AIDS Res Hum Retroviruses       Date:  2013-12-09       Impact factor: 2.205

3.  Innovative sensory methods to access acceptability of mixed polymer semisoft ovules for microbicide applications.

Authors:  Toral Zaveri; Cordelia A Running; Lahari Surapaneni; Gregory R Ziegler; John E Hayes
Journal:  Drug Deliv Transl Res       Date:  2016-10       Impact factor: 4.617

4.  User-identified gel characteristics: a qualitative exploration of perceived product efficacy of topical vaginal microbicides.

Authors:  Kathleen M Morrow; Kristen Underhill; Jacob J van den Berg; Sara Vargas; Rochelle K Rosen; David F Katz
Journal:  Arch Sex Behav       Date:  2014-01-23

5.  Mathematical insights in evaluating state dependent effectiveness of HIV prevention interventions.

Authors:  Yuqin Zhao; Dobromir T Dimitrov; Hao Liu; Yang Kuang
Journal:  Bull Math Biol       Date:  2013-02-23       Impact factor: 1.758

Review 6.  Methodological lessons from clinical trials and the future of microbicide research.

Authors:  Ariane van der Straten; Elizabeth T Montgomery; Miriam Hartmann; Alexandra Minnis
Journal:  Curr HIV/AIDS Rep       Date:  2013-03       Impact factor: 5.071

7.  Disclosure of microbicide gel use to sexual partners: influence on adherence in the CAPRISA 004 trial.

Authors:  Kathryn Therese Mngadi; Silvia Maarschalk; Anneke C Grobler; Leila E Mansoor; Janet A Frohlich; Bernadette Madlala; Nelisiwe Ngcobo; Salim S Abdool Karim; Quarraisha Abdool Karim
Journal:  AIDS Behav       Date:  2014-05

8.  Relationship Type and Use of the Vaginal Ring for HIV-1 Prevention in the MTN 020/ASPIRE Trial.

Authors:  E Pleasants; T Tauya; K Reddy; B G Mirembe; K Woeber; T Palanee-Phillips; C Zimba; M Atujuna; E T Montgomery
Journal:  AIDS Behav       Date:  2020-03

9.  Factors Supporting and Hindering Adherence to Rectal Microbicide Gel Use with Receptive Anal Intercourse in a Phase 2 Trial.

Authors:  Rebecca Giguere; Christine Tagliaferri Rael; Alan Sheinfil; Ivan C Balán; William Brown; Titcha Ho; Curtis Dolezal; Cheng-Shiun Leu; Albert Liu; Kenneth H Mayer; Javier R Lama; Ian McGowan; Alex Carballo-Diéguez; Ross D Cranston
Journal:  AIDS Behav       Date:  2018-02

10.  Adherence and acceptability in MTN 001: a randomized cross-over trial of daily oral and topical tenofovir for HIV prevention in women.

Authors:  Alexandra M Minnis; Sharavi Gandham; Barbra A Richardson; Vijayanand Guddera; Beatrice A Chen; Robert Salata; Clemensia Nakabiito; Craig Hoesley; Jessica Justman; Lydia Soto-Torres; Karen Patterson; Kailazarid Gomez; Craig W Hendrix
Journal:  AIDS Behav       Date:  2013-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.